论文部分内容阅读
In recent years, the clinical incidence of thyroid cancer hasrnbeen increasing year by year, and its risk assessment andrnclinical management methods have also been accordinglyrnmodified and constantly improved. There are greatrndifferences between the clinical diagnostic and therapeuticrnmodes and disease management of thyroid cancer employed by various medical institutions in China, particularly withrnregard to the clinical application of serum marker of thyroidrncancer.